SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: dr.praveen who wrote (149)7/25/2006 10:06:07 AM
From: idos  Read Replies (1) | Respond to of 3027
 
Looks like some people knew about this Collaboration one day before the announcement...



To: dr.praveen who wrote (149)7/25/2006 10:15:30 AM
From: rkrw  Read Replies (2) | Respond to of 3027
 
I like the affirmation of mnta in expanding beyond lovenox by the top tier Sandoz. Also like that mnta snagged stakes in a couple of late stage Sandoz programs. Main disappointment is they didn't disclose the mystery generic. Hopefully better detail in the cc. Also wish the $75M wasn't in equity, but $75M is nice, especially when this years burn rate is supposed to be $35M.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News